The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
Open accessAbstract
BACKGROUND: Rotavirus is the most common cause of severe gastroenteritis among young children worldwide. Data are needed to assess the efficacy of the rotavirus vaccine in African children. METHODS: We conducted a randomized, placebo-controlled, multicenter trial in South Africa (3166 infants; 64.1% of the total) and Malawi (1773 infants; 35.9% of the total) to evaluate the efficacy of a live, oral rotavirus vaccine in preventing severe rotavirus gastroenteritis. Healthy infants were randomly assigned in a 1:1:1 ratio to receive two doses of vaccine (in addition to one dose of placebo) or three doses of vaccine--the pooled vaccine group--or three doses of placebo at 6, 10, and 14 weeks of age. Episodes of gastroenteritis caused by wild-type rotavirus during the first year of life were assessed through active follow-up surveillance and were graded with the use of the Vesikari scale. RESULTS: A total of 4939 infants were enrolled and randomly assigned to one of the three groups; 1647 infants received two doses of the vaccine, 1651 infants received three doses of the vaccine, and 1641 received placebo. Of the 4417 infants included in the per-protocol efficacy analysis, severe rotavirus gastroenteritis occurred in 4.9% of the infants in the placebo group and in 1.9% of those in the pooled vaccine group (vaccine efficacy, 61.2%; 95% confidence interval, 44.0 to 73.2). Vaccine efficacy was lower in Malawi than in South Africa (49.4% vs. 76.9%); however, the number of episodes of severe rotavirus gastroenteritis that were prevented was greater in Malawi than in South Africa (6.7 vs. 4.2 cases prevented per 100 infants vaccinated per year). Efficacy against all-cause severe gastroenteritis was 30.2%. At least one serious adverse event was reported in 9.7% of the infants in the pooled vaccine group and in 11.5% of the infants in the placebo group. CONCLUSIONS: Human rotavirus vaccine significantly reduced the incidence of severe rotavirus gastroenteritis among African infants during the first year of life. (ClinicalTrials.gov number, NCT00241644.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M. J., Heyse, J. F., Goveia, M. G., Black, S. B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052664 · Cited by 1,873
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Ruiz-Palacios, G. M., Pérez-Schael, I., Velázquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052434 · Cited by 1,799
Self-citationSantos, N., & Hoshino, Y. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.448 · Cited by 1,251
Intussusception among Infants Given an Oral Rotavirus Vaccine
Murphy, T. V., Gargiullo, P. M., Massoudi, M. S., Nelson, D. B., Jumaan, A. O., Okoro, C. A., Zanardi, L. R., Setia, S., Fair, E., LeBaron, C. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440804 · Cited by 973
Rotavirus Infection in Infants as Protection against Subsequent Infections
Velázquez, F. R., Matson, D. O., Calva, J. J., Guerrero, M. L., Morrow, A. L., Carter-Campbell, S., Glass, R. I., Estes, M. K., Pickering, L. K., & Ruiz-Palacios, G. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351404 · Cited by 836
Ruuska, T., & Vesikari, T. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027046 · Cited by 714
Rotavirus infection in infants as protection against subsequent infections
(1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)80038-8 · Cited by 674
Vesikari, T., Karvonen, A., Prymula, R., Schuster, V, Tejedor, J., Cohen, R., Meurice, F., Han, H., Damaso, S., & Bouckenooghe, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61744-9 · Cited by 636
Self-citationGentsch, J. R., Laird, A. R., Bielfelt, B., Griffin, D. D., Bányai, K., Ramachandran, M., Jain, V., Cunliffe, N. A., Nakagomi, O., Kirkwood, C. D., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/431499 · Cited by 624
Self-citationClark, A., & Sanderson, C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60317-2 · Cited by 343
Cited by
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Tate, J. E., Burton, A. H., Boschi-Pinto, C., Steele, A. D., Duque, J., & Parashar, U. D. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70253-5 · Cited by 1,277
The pig: a model for human infectious diseases
Meurens, F., Summerfield, A., Nauwynck, H., Saif, L., & Gerdts, V. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.002 · Cited by 999
Zaman, K., Anh, D. D., Victor, J. C., Shin, S., Yunus, M., Dallas, M. J., Podder, G., Thiem, V. D., Mai, L. T. P., Luby, S. P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60755-6 · Cited by 824
Self-citationRecent progress in mucosal vaccine development: potential and limitations
Lycke, N. (2012) · Nature Reviews Immunology · doi:10.1038/nri3251 · Cited by 807
Crawford, S. E., Ramani, S., Tate, J. E., Parashar, U. D., Svensson, L., Hagbom, M., Franco, M. A., Greenberg, H. B., O'Ryan, M., Kang, G., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.83 · Cited by 687
Armah, G. E., Sow, S. O., Breiman, R. F., Dallas, M. J., Tapia, M. D., Feikin, D. R., Binka, F. N., Steele, A. D., Laserson, K. F., Ansah, N. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60889-6 · Cited by 654
Self-citationBányai, K., Estes, M. K., Martella, V., & Parashar, U. D. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31128-0 · Cited by 445
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Soares‐Weiser, K., MacLehose, H. G., Bergman, H., Ben‐Aharon, I., Nagpal, S., Goldberg, E., Pitan, F., & Cunliffe, N. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008521.pub3 · Cited by 381
Self-citationThe MAL-ED Network Investigators, Acosta, A. M., Chavez, C. B., Flores, J. T., Olotegui, M. P., Pinedo, S. R., Trigoso, D. R., Vasquez, A. O., Ahmed, I., Alam, D., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu653 · Cited by 377
Desselberger, U. (2014) · Virus Research · doi:10.1016/j.virusres.2014.06.016 · Cited by 376
Kotloff, K. L., Blackwelder, W. C., Nasrin, D., Nataro, J. P., Farag, T. H., van Eijk, A., Adegbola, R. A., Alonso, P. L., Breiman, R. F., Golam Faruque, A. S., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis753 · Cited by 373
Bhandari, N., Rongsen-Chandola, T., Bavdekar, A., John, J., Antony, K., Taneja, S., Goyal, N., Kawade, A., Kang, G., Rathore, S. S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62630-6 · Cited by 326
Harris, V. C., Armah, G., Fuentes, S., Korpela, K. E., Parashar, U., Victor, J. C., Tate, J., de Weerth, C., Giaquinto, C., Wiersinga, W. J., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw518 · Cited by 299
Self-citationLevine, M. M. (2010) · BMC Biology · doi:10.1186/1741-7007-8-129 · Cited by 261
do Carmo, G. M. I., Yen, C., Cortes, J., Siqueira, A. A., de Oliveira, W. K., Cortez-Escalante, J. J., Lopman, B., Flannery, B., de Oliveira, L. H., Hage Carmo, E., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001024 · Cited by 260
Fletcher, S. M., McLaws, M.-L., & Ellis, J. T. (2013) · Journal of Public Health Research · doi:10.4081/jphr.2013.e9 · Cited by 172
Immune system development varies according to age, location, and anemia in African children
Hill, D. L., Carr, E. J., Rutishauser, T., Moncunill, G., Campo, J. J., Innocentin, S., Mpina, M., Nhabomba, A., Tumbo, A., Jairoce, C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw9522 · Cited by 89
Modeling the complexities of water, hygiene, and health in Limpopo Province, South Africa
Mellor, J. E., Smith, J. A., Learmonth, G. P., Netshandama, V. O., & Dillingham, R. A. (2012) · Environmental Science & Technology · doi:10.1021/es3038966 · Cited by 25
Metadata
- Authors
- Madhi, S. A., Cunliffe, N. A., Steele, D., Witte, D., Kirsten, M., Louw, C., Ngwira, B., Victor, J. C., Gillard, P. H., Cheuvart, B. B., Han, H. H., & Neuzil, K. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-01-28
- Volume
- 362
- Issue
- 4
- Pages
- 289-298
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2113014022
- Cited by
- 886
- References
- 18
- FWCI
- 55.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.